PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2121566
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2121566
According to Mordor Intelligence, the anesthesia monitoring devices market size was valued at USD 2.91 billion in 2025 and estimated to grow from USD 3.2 billion in 2026 to reach USD 5.12 billion by 2031, at a CAGR of 9.86% during the forecast period (2026-2031).

This report Segments the Industry Into by Product (Basic Anesthesia Monitor, Integrated Anesthesia Workstation, and More), Parameter Monitored (Oxygenation, Ventilation, Circulation, and More), by End User (Hospitals, Ambulatory Surgery Centers, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).
Automated anesthesia information management systems (AIMS) slash manual charting errors by 40%, freeing clinicians to focus on patient care . Philips' IntelliSpace Critical Care and Anesthesia illustrates this trend with touch-optimized dashboards that feed real-time vitals directly into electronic health records . Closed-loop controllers already outmatch manual titration for hemodynamic stability, setting the stage for precision protocols driven by historical machine-learning feedback . Such gains meet a dual objective: higher safety margins and lower clinician burnout tied to administrative load. As a result, hospitals treat integrated AIMS as the core of a data-rich anesthesia monitoring devices market strategy.
Patient expectations around rapid, opioid-sparing recovery are fueling multimodal techniques that hinge on objective nociception metrics. The NOL Index(R) finger probe converts four photoplethysmography channels into a 0-100 pain score, assisting anesthesiologists in tailoring analgesia . Validation studies confirm uniform accuracy across racial groups because infrared wavelengths and personalized algorithms normalize individual responses, answering equity concerns in perioperative care. In ASCs, where same-day discharge is the norm, NOL monitoring dovetails with ERAS pathways to curb respiratory depression and hasten mobilization. Consequently, pain-free protocols bolster the anesthesia monitoring devices market as facilities invest in sensors that align with patient-centric outcomes.
Economic assessments show BIS monitoring costs USD 10,000-25,000 per avoided recall event, potentially adding USD 1 billion in annual spend if universally adopted. TIVA also presents higher variable expenses than low-flow inhalational strategies, leading resource-constrained systems to favor legacy monitors. Budget pressures, training overhead, and regulatory inertia slow advanced-device uptake, placing a drag on the anesthesia monitoring devices market where basic monitors suffice for routine cases.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Integrated workstations dominated with 40.72% share of the anesthesia monitoring devices market in 2025 as hospitals demanded single-console solutions that house gas delivery, ventilators, and monitors. Advanced monitors, though smaller in installed base, expand 10.62% CAGR by 2031, leveraging AI modules for brain and pain metrics that retrofit onto existing theaters. Basic monitors and consumables sustain the lower-cost layer, particularly in emerging markets and as redundancy backups. GE Healthcare's Aisys(TM) CS2 automates fresh-gas delivery, illustrating how workstation platforms integrate sustainability and cost savings, making them indispensable anchors within the anesthesia monitoring devices market.
Consumables show steady growth tied to procedure counts rather than capital cycles. Cyber-security is shaping purchase criteria; unified workstations reduce attack surfaces compared with disparate single-parameter devices. Consequently, procurement teams increasingly assess cyber-resilience alongside clinical performance, further buttressing integrated solutions' appeal in the anesthesia monitoring devices industry.
North America generated 38.15% revenue for the anesthesia monitoring devices market in 2025 on the back of early AI adoption, reimbursement coverage, and a consolidated supplier base. Regulatory clarity and cybersecurity guidance from agencies such as CISA speed procurement decisions, while major vendors leverage domestic manufacturing footprints to navigate supply-chain shocks.
Asia-Pacific leads with a 10.69% CAGR through 2031 as China and India escalate localization. China's device market is slated to climb from USD 36.35 billion in 2024 to USD 55.67 billion by 2029, supported by Made in China 2025 incentives that cut import reliance from 85% toward sub-50% thresholds. India restricts refurbished imports and aims for a USD 50 billion MedTech sector by 2030, opening avenues for indigenous anesthesia monitoring platforms. These moves enlarge the anesthesia monitoring devices market size across regional OEMs and global joint-venture partners.
Europe maintains mid-single-digit growth under the EU Medical Device Regulation, which nudges suppliers toward eco-design and post-market surveillance that strengthen buyer confidence. Middle East and Africa attract hospital-build projects tied to medical tourism corridors in the Gulf, spawning demand for integrated workstations with multilingual user interfaces. South America shows pockets of acceleration in Brazil and Argentina as public hospitals modernize, yet currency volatility keeps procurement cycles uneven. Altogether, geographic diversification cushions the anesthesia monitoring devices market against region-specific shocks and sustains double-digit global expansion.